Genetic Evidence that InhA of <i>Mycobacterium smegmatis</i> Is a Target for Triclosan

Laura M. McMurry, Patrick F. McDermott, Stuart B. Levy

Antimicrobial Agents and Chemotherapy · 1999 · 213 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Three Mycobacterium smegmatis mutants selected for resistance to triclosan each had a different mutation in InhA, an enoyl reductase involved in fatty acid synthesis. Two expressed some isoniazid resistance. A mutation originally selected on isoniazid also mediated triclosan resistance, as did the wild-type inhA gene on a multicopy plasmid. Replacement of the mutant chromosomal inhA genes with wild-type inhA eliminated resistance. These results suggest that M. smegmatis InhA, like its Escherichia coli homolog FabI, is a target for triclosan.

References

13